Skip to content Skip to left sidebar Skip to footer

Archive (Pre-Jan 2010) – Quality Improvement Studies

Year 9 ~ Contract Extension (2009)

July thru December 2009


Year 8 ~ (2008-2009)


Year 7 ~ (2007-2008)


Year 6 ~ (2006-2007)


Year 5 ~ (2005-2006)

Barriers Analysis

CORE Driver Elements and Outcomes

Longitudinal Panel/WSC Turnover Impact

Psychotherapeutic Drug Use

Supports Prediction Model

Waiver Support Coordinator Caseload Impact


Year 4 ~ (2004-2005)

Outcome Results Analysis

Collaborative Outcome Review and Enhancement (CORE)

Consumer-Directed Care Plus (CDC+) Outcomes & Supports Analysis

Personal Outcome Measures

Psychotherapeutic Drug Use

Year 4 Evaluation of Use of Selected Psychotherapeutic Drug Profiles in Florida’s Developmental Disabilities Home and Community-Based Services Waiver

Public Reporting


Year 3 ~ (2003-2004)

Desk Review

Personal Outcome Measures

Psychotherapeutic Drug Use

Use of Selected Psychotherapeutic Drug Profiles in Persons with Developmental Disabilities in Florida’s Developmental Disabilities Home and Community Based Services Waiver

Public Reporting


Year 2 ~ (2002-2003)

Psychotherapeutic Drug Use

Psychotherapeutic Medication Use in Persons with Developmental Disabilities in Florida’s Developmental Services Home and Community-Based Services Waiver
July 7, 2003


Year 1 ~ (2001-2002)

Psychotherapeutic Drug Use

The Epidemiology of Anti-Seizure and Psychotropic Medication Use in Persons with Developmental Disabilities in Florida on the Developmental Disabilities Home and Community-Based Services Waiver